iNVEZZ.com, Tuesday, July 22: Shire’s (LON:SHP) chief executive Flemming Ornskov is due to receive just under $10 million after agreeing to remain with the rare disease specialist following its takeover by US drugmaker AbbVie (NYSE:ABBV). Shire’s share price has lost more than one percent in London so far this morning.
Help employers find you! Check out all the jobs and post your resume.
